Table 1:
Viability of HL-60 cells during incubation with cytarabine, combination of cytarabine with hippuric acid, and cytarabine with HAN nanocomposite.
Concentration of Cyta (
μ
g/ml)
Viability (%)
Concentration of Cyta : HA or HAN (
μ
g/mL)
Viability (%)
HA
HAN
20.0
1.6
20 : 20
1.4
1.2
10.0
2.4
10 : 10
2.4
1.6
5.0
2.4
5 : 5
2.2
1.5
2.5
2.6
2.5 : 2.5
2.1
1.9
1.25
5.7
1.25 : 1.25
5.1
2.3
0.625
5.5
0.625 : 0.625
5.6
3.5
0.3125
9.4
0.3125 : 0.3125
9.6
5.8
0.00
100.0
0 : 0
100.0
100.0